Tesla’s Stock Skyrockets on AI Hype – Latest Price Jump, Earnings Shocks & Bold 2025 Forecasts

Tesla Stock Today (Nov 7, 2025): TSLA Slides After Shareholders Approve Elon Musk’s $1 Trillion Pay Package

Summary: Tesla (NASDAQ: TSLA) shares fell on Friday as Wall Street digested the historic shareholder vote to approve CEO Elon Musk’s new, performance‑based compensation plan. The package—headlined at $1 trillion (about $878 billion net after offsets)—passed with more than 75% support at Tesla’s annual meeting on November 6. TSLA closed down 3.68% at $429.52, extending a two‑day decline to roughly 7%. [1]


What moved TSLA on Nov 7

  • Shareholders approved Musk’s record plan. Investors overwhelmingly backed the 10‑year award tied to aggressive milestones spanning market value, profits, autonomy, and robotics. The plan targets an $8.5 trillion market capitalization and envisions robotaxis and humanoid robots at scale. Reuters and AP both reported a vote share above 75%. [2]
  • Stock fell on the news. Despite the vote, TSLA dropped on Friday as investors weighed governance optics, dilution mechanics, and execution risk embedded in the package. Reuters noted Tesla shares fell ~3.7% on the day while the broader market finished mixed. [3]
  • An xAI tie‑up authorization did not pass. A shareholder proposal asking the board to authorize an investment in Musk’s AI company xAI received more “for” than “against” votes but failed because Tesla’s bylaws count abstentions as votes against; the board said it will “examine next steps.” (See official 8‑K tallies below.) [4]

Official vote results at a glance (Tesla 8‑K)

Tesla filed an 8‑K detailing vote counts for 14 proposals from the Nov. 6 annual meeting. Key outcomes:

  • Proposal 4 – Approve the 2025 CEO Performance Award:For 1,892,235,822 | Against 564,940,908 | Abstain 12,227,846 → Approved. [5]
  • Proposal 7 – Authorize Board investment in xAI (advisory):For 1,058,999,435 | Against 916,321,296 | Abstain 473,073,200 → Not approved due to abstentions counting as “against” under bylaws. [6]
  • Proposal 12 – Elect directors annually:Approved (1,328,135,664 for / 1,118,920,427 against). [7]
  • Proposal 6 – Eliminate supermajority voting:Not approved. [8]
  • Other items: Executive compensation (advisory) and the amended 2019 equity plan were approved; proposals on a child‑labor audit and certain bylaw changes failed. [9]

Why it matters: The filing locks in the outcome and clarifies that, on xAI specifically, the vote does not authorize an investment, despite a raw plurality “for.” Separately, press coverage on Thursday and Friday highlighted the scale and conditions of Musk’s award (and that the headline $1T equates to about $878B net after offsets), framing the plan as both audacious and contentious. [10]


Why investors sold Tesla on the news

Governance & dilution optics. Several large institutions (e.g., Norway’s sovereign wealth fund) opposed the plan on size and concentration‑of‑power grounds; analysts expressed mixed views on the risk/reward, even while acknowledging Musk’s centrality to Tesla’s AI roadmap. [11]

Execution risk. The performance gates—$8.5T market cap, expanded autonomy, and scaled robotics—are extraordinary. Supporters frame the package as “pay for performance”; skeptics question achievability and whether the focus diverts attention from near‑term EV fundamentals. [12]

Macro backdrop. Friday’s broader tape was mixed: S&P 500 +0.13%, Dow +0.16%, Nasdaq −0.21%. Risk appetite has been whipsawed by macro headlines, and high‑beta tech names underperformed. Against that setting, Tesla’s idiosyncratic news met a softer risk tone. [13]


TSLA by the numbers (Nov 7, 2025 close)

  • Close:$429.52 (−3.68% day‑over‑day)
  • Range:$421.88–$439.36
  • Two‑day move (Thu–Fri): roughly −7% (Fri close vs. Wed close)
  • Volume:>100 million shares traded
    (Official historical prints from Investing.com.) [14]

What Wall Street is saying

Early reactions span from “extreme but potentially justified if targets are met” to concerns about “unchecked power” and near‑term EV demand. In short, the Street sees the award as a high‑beta bet on Musk executing a pivot from “just an automaker” to a platform spanning AI, robotaxis, and humanoid robots. [15]


Beyond the vote: what to watch next

  • Regulatory path for autonomy in China. Musk said Tesla expects full regulatory approval for FSD in China by early 2026; any concrete steps toward that timeline would be a major catalyst for the autonomy narrative. [16]
  • Board follow‑up on the xAI vote. The board said it will examine next steps given the high number of abstentions; investors should watch for any revised proposal or clarified framework to manage conflicts of interest. [17]
  • Operational checkpoints. Delivery trends, margin trajectory, and updates on automation/robotics progress will determine whether the performance tranches in the award are realistically in play. (See Tesla’s 8‑K exhibits and proxy materials for award mechanics.) [18]

Key takeaways for today (Nov 7)

  • Historic compensation plan approved; exact tallies now on file with the SEC. [19]
  • TSLA fell despite the win, as investors focused on governance optics and execution risk. [20]
  • xAI authorization failed under Tesla’s abstention rule; the board will reassess. [21]
  • Stock closed at $429.52, extending a two‑day slide to about 7%. [22]

FAQs: Tesla stock today (7 Nov 2025)

Did Tesla approve Elon Musk’s $1T pay package?
Yes. Shareholders approved the 2025 CEO Performance Award with ~1.89B votes “for” vs. 0.56B “against.” [23]

Did shareholders authorize Tesla to invest in xAI?
No. Although more votes were cast “for” than “against,” abstentions counted as “against” under Tesla’s bylaws, so the advisory proposal did not pass. [24]

Where did TSLA finish today?
TSLA closed at $429.52 (−3.68%); intraday range $421.88–$439.36. [25]

How did the broader market trade?
The S&P 500 (+0.13%) and Dow (+0.16%) edged higher, while the Nasdaq (−0.21%) slipped. [26]


Disclosure

This article is for informational purposes only and does not constitute investment advice. Do your own research and consider consulting a licensed financial advisor.

Sources: Tesla SEC filing (Form 8‑K), Reuters, Associated Press, and Investing.com historical data. [27]

Editor’s note: This story covers developments on Nov 6–7, 2025 and will not auto‑update after publication.

Tesla shareholders approve Elon Musk’s potential $1 trillion compensation deal

References

1. www.reuters.com, 2. www.reuters.com, 3. www.reuters.com, 4. ir.tesla.com, 5. ir.tesla.com, 6. ir.tesla.com, 7. ir.tesla.com, 8. ir.tesla.com, 9. ir.tesla.com, 10. www.reuters.com, 11. www.reuters.com, 12. www.reuters.com, 13. www.reuters.com, 14. www.investing.com, 15. www.reuters.com, 16. www.reuters.com, 17. ir.tesla.com, 18. ir.tesla.com, 19. ir.tesla.com, 20. www.reuters.com, 21. ir.tesla.com, 22. www.investing.com, 23. ir.tesla.com, 24. ir.tesla.com, 25. www.investing.com, 26. www.reuters.com, 27. ir.tesla.com

Stock Market Today

  • PRMB Stock Turbulence Deepens as Market Shifts Hit Financials
    November 8, 2025, 9:04 AM EST. PRMB stock continues under pressure as market shifts deepen a bleak outlook. The shares are down roughly 17.96% amid persistent volatility. Key metrics show a mixed picture: revenue of $5.15B with a negative net profit margin (-0.47%) but a solid 27.4% gross margin; EBIT margin 4.5% and pretax margin 2% suggest operational headwinds. Leverage remains elevated-debt-to-equity 1.76 and leverage 3.4-even as free cash flow prints $150.7M. Technicals point to a sustained downtrend, with the stock sliding from $22.66 to $14.52 and weak support near $14.50. Outlook is cautious; upside catalysts are unclear and sentiment fragile. Traders may look for short-sell opportunities if bears fail to reclaim key levels.
  • DigitalOcean DOCN's 31% surge prompts P/E debate as earnings outlook dims
    November 8, 2025, 8:48 AM EST. DigitalOcean Holdings, Inc. (NYSE:DOCN) has jumped 31% in the last 30 days, and 29% for the year, keeping the stock in the spotlight. The stock's P/E of 18x sits near the US market median, suggesting valuations haven't yet priced in a meaningful earnings downturn. Analysts still expect next-year earnings to fall by about 58% (from eleven analysts), even as broader markets are seen growing around 16%. The company showed explosive earnings growth recently (about 203% year over year) but longer-term growth has been tepid. With a mixed growth backdrop and a potentially weaker outlook, the rally may be vulnerable if earnings disappoint and multiple expansion stalls. Investors should weigh the earnings trend, analyst estimates, and sector dynamics before chasing further gains.
  • Is Akero Therapeutics (AKRO) Valuation Justified Amid Recent Momentum?
    November 8, 2025, 8:44 AM EST. Akero Therapeutics (AKRO) has marched higher this month, up about 16%, with a scorching 92.5% year-to-date climb and a quiet news cycle. Investors are reevaluating the stock's path as momentum builds. At a P/B ratio of 4.2x, Akero trades well above the industry average of 2.4x, signaling a premium placed on anticipated growth or potential breakthroughs-noting the company still generates no revenue and remains unprofitable. The stock's uptick raises the question: is there more room to run, or has the market already baked in its future upside? The high multiple implies a fragile balance between upside potential and execution risk around clinical milestones and commercialization. Risks include missed milestones or delays, which could compress valuations even as optimism persists.
  • Is MillerKnoll's Options Market Betting on a Move? What Traders Should Know
    November 8, 2025, 8:42 AM EST. MillerKnoll, Inc. (MLKN) is drawing attention as the options market shows elevated implied volatility around the Nov. 21, 2025 $15 call, signaling traders anticipate a potential big move in the shares. High IV often reflects upcoming events or uncertainty, and may lend itself to premium selling strategies as investors bet on limited post-expiration movement. On the fundamentals, Zacks ranks MillerKnoll #2 Buy in the Furniture group, though the latest 60-day revisions show earnings estimates slipping from 42 cents to 40 cents per share this quarter. The mismatch between bullish option pricing and modest earnings momentum could be a setup for a volatility-driven trade rather than a straightforward stock rally. Traders should weigh the implied move against the core business picture and their risk tolerance.
  • Implied Volatility Surges in Progressive Corporation Options (PGR) on Nov 21, 2025 Call
    November 8, 2025, 8:40 AM EST. Investors are watching The Progressive Corporation (PGR) as options traders push implied volatility higher for near-term moves. The standout is the Nov. 21, 2025 $155 Call, which showed some of the highest IV among equity options today. Implied volatility gauges how much the market expects the stock to move and often signals a potential event or earnings surprise. While IV can hint at a big rally or sell-off, it's only one piece of the puzzle. Analysts currently rate PGR as a Zacks Rank #3 (Hold) within the Insurance - Property and Casualty group, with earnings estimates edging up to $4.43 this quarter. Some traders may attempt to sell premium to capture time decay if the stock moves less than expected.
Oracle (ORCL) Stock Rockets 70% on AI Frenzy – Jim Cramer Warns “It’s the Only One I’m Worried About”
Previous Story

Oracle (ORCL) Stock Today, Nov. 7, 2025: $239 Close as $18B AI Data‑Center Financing and Oracle‑Linked Cyber Breach Dominate the Tape

Microsoft Stock Soars on AI and Cloud Frenzy – Analysts Eye $600+ Price Targets
Next Story

Microsoft Stock Today (MSFT): Eight‑Day Slide Hits Longest Streak Since 2011 — Close, Catalysts, and What’s Next (Nov 7, 2025)

Go toTop